The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes of nivolumab (NIVO) given sequentially with ipilimumab (IPI) in patients with advanced melanoma (CheckMate 064).
 
Jeffrey S. Weber
Stock and Other Ownership Interests - Altor BioScience; Celldex; Merck
Honoraria - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Consulting or Advisory Role - Abbvie; Altor BioScience; Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Eisai; Genentech; GlaxoSmithKline; Ichor Medical Systems; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Celldex; Daiichi Sankyo; Genentech; GlaxoSmithKline; Lion Biotechnologies; Merck; Merck; Pieris Pharmaceuticals; Roche
 
Geoffrey Thomas Gibney
Honoraria - Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Novartis
 
Ryan J. Sullivan
Consulting or Advisory Role - Astex Pharmaceuticals; Biodesix; Novartis; Prometheus
Other Relationship - Boehringer Ingelheim
 
Jeffrey Alan Sosman
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Novartis (Inst)
 
Craig L. Slingluff
Honoraria - Castle Biosciences
Consulting or Advisory Role - immatics (Inst); Polynoma (Inst)
Research Funding - 3M (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); immatics (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - UVA Licensing
 
Donald P. Lawrence
No Relationships to Disclose
 
Theodore F. Logan
Consulting or Advisory Role - Argos Therapeutics; AVEO; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Novartis; Pfizer; Prometheus; Wyeth
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer; Prometheus; Wyeth
Research Funding - Abbott Laboratories (Inst); Abraxis BioScience (Inst); Acceleron Pharma (Inst); Amgen (Inst); Argos Therapeutics (Inst); AstraZeneca (Inst); AVEO (Inst); BioVex (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); GlaxoSmithKline (Inst); immatics (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); Roche (Inst); Synta (Inst); Threshold Pharmaceuticals (Inst); TRACON Pharma (Inst)
 
Lynn Mara Schuchter
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche (Inst)
 
Suresh Nair
Research Funding - Bristol-Myers Squibb; Celldex
 
Elizabeth Iannotti Buchbinder
Employment - Merck (I)
Consulting or Advisory Role - Castle Biosciences; Immune Design
 
Elmer Berghorn
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Joel Jiang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Christine E. Horak
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
F. Stephen Hodi
Consulting or Advisory Role - Amgen; Genentech/Roche; Merck Sharp & Dohme; Novartis
Research Funding - bristol-myers squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); novartis (Inst)
Patents, Royalties, Other Intellectual Property - patent pending as per institutional policy; patent pending royalties received on MICA related disorders application to institution per institutional IP policy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
Other Relationship - Bristol-Myers Squibb; Genentech/Roche